BASF India Approves Closure of Sulfate and Reactor Plants in Dahej Care Chemicals Business
BASF India Limited has approved the closure of specific manufacturing units pertaining to its Care Chemicals business at the Dahej facility. The decision was made following a meeting of the Board of Directors, held on August 4, 2026.The plants targeted for closure include the sulfation and low temperature reactor plants within the Company's Care Chemicals operations in Dahej. The closure move is attributed to the changing competitive landscape in India, which has resulted in extensive overcapacities, high costs, and margin pressure across relevant segments.
The company stated that these facilities of the Care Chemicals business are expected to be closed by the end of calendar year 2026, contingent upon receiving all requisite approvals.
In terms of its broader strategy for the Care Chemicals division, BASF India will continue manufacturing, importing, and selling other chemical products to customers in India based on their specific requirements.
During the financial year 2025-26, the manufacturing operations belonging to the Care Chemicals Business at the Dahej site, which falls under the Nutrition & Care Segment, contributed a specific portion of revenue to the company.
The financial contribution details for the relevant segment in FY 2025-26 are summarized below:
| Metric | Value |
|---|---|
| Revenue from Care Chemicals Operations (FY 2025-26) | Rs. 542 crore |
| Share of Total Company Revenues | 4% |
BASF Stock Price Movement
Shares of BASF India Limited are edging higher to ₹4156 as of 2:09 PM, having surged over 11.43% in the live trading session. The stock traded 230,596 shares and maintained a strong position within its intraday range, climbing close to the session high of ₹4250 against a low near ₹3713.5.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.